AHC Media, Feb. 25, 2008 This article discusses investment opportunities for biotech companies and mentions UTMB and its partnership with VaxInnate Corp. The company has received funding as part of a $9.5 million grant to UTMB from the Gates Foundation to develop a pandemic influenza vaccine for use in the developing world.